Search Results

Cancer Cryoablation Treatments at Southeast Region Nuclear Medicine Center in Korea Exceed 100 Cases

The Southeast Region Nuclear Medicine Center announced on August 8 that since introducing cancer cryoablation in 2024, the center has completed over 100 related procedures, providing treatment to a total of 104 cancer patients. Cryoablation is a minimally invasive tumor treatment method. During the procedure, doctors insert a thin treatment needle precisely into the tumor site under CT or ultrasound imaging guidance, freezing the lesion at ultra-low temperatures of minus 40 degrees Celsius or lower to cause cancer cell necrosis. As the low-temperature freezing itself has a certain anesthetic effect, this technique helps reduce patient pain, minimize damage to surrounding normal tissues, and promote faster postoperative recovery. According to the center, among the patients treated so far, there are 58 cases of liver cancer and liver metastases, 17 cases of primary lung cancer, recurrent lung cancer, and lung metastases, and 29 cases of renal cancer. Among them, 8 patients underwent treatment for two lesions simultaneously in a single procedure. Liver...

2026-08-08

CNNC Delegation Visits Chen Dexin, Party Secretary and Chairman of China Minmetals

On August 7, Shen Yanfeng, Party Secretary and Chairman of CNNC, led a delegation to China Minmetals Corporation to meet with Chen Dexin, Party Secretary and Chairman of China Minmetals, where both parties exchanged views on further strengthening strategic cooperation. Wang Jiezhi, Deputy Party Secretary and Director of China Minmetals, Wang Xingquan, Party Member and Vice President, Liu Jianping, Deputy Party Secretary and Director of CNNC, and Chen Junli, Party Member and Vice President, attended the meeting. Chen Dexin welcomed the visit of Shen Yanfeng and his delegation, and introduced the business segments of China Minmetals. He stated that since the signing of the strategic cooperation agreement between China Minmetals and CNNC, fruitful cooperation results have been achieved in multiple fields, including uranium resource development, overseas nuclear power construction, and scientific research project breakthroughs...

2026-08-08

Mutsu City Requests Submission of Revised Plan for 5,000-Ton Transport to Spent Fuel Interim Storage Facility

On August 7, Tomoya Yamamoto, Mayor of Mutsu City, Aomori Prefecture, Japan, met with representatives of Recycle Fuel Storage (RFS) and its co-investors Tokyo Electric Power Company Holdings (TEPCO HD) and Japan Atomic Power Company (JAPC), requesting the three parties to submit a revised mid-to-long-term spent nuclear fuel transport plan, with consideration given to inter-operator cooperation. The plan may involve accepting spent nuclear fuel from other electric power companies. The facility in question, located in Mutsu City, Aomori Prefecture, is currently Japan's only interim spent fuel storage facility situated outside a nuclear power plant site. Under the existing siting agreement, the facility's acceptance scope...

2026-08-08

Shanghai Electric Southwest Regional Headquarters Unveiled in Chengdu, Government-Enterprise-Research Collaboration Builds a New Hub for Green Energy

On August 6, the unveiling ceremony of the Southwest Regional Headquarters of Shanghai Electric Group was held in Chengdu. Jin Xiaolong, member of the Party Committee and Vice President of Shanghai Electric, attended the event and delivered a speech. More than 200 representatives from relevant government departments of Sichuan Province, Chengdu City and the Southwest region, the Shanghai Office in Tibet, key enterprises, research institutes, industry associations, as well as heads of relevant functional departments of Shanghai Electric headquarters and various industrial groups, participated in the event. The newly unveiled Southwest Regional Headquarters will be based in Chengdu, radiating to Sichuan, Chongqing, Yunnan, Guizhou and Tibet, positioned as a collaboration platform for the regional market, a service hub for industrial upgrading, and a connecting vehicle for ecosystem co-building, integrating Shanghai Electric's comprehensive advantages in energy equipment and green intelligent industry...

2026-08-08

Belarus and Uzbekistan Plan Energy Cooperation Roadmap, Nuclear Power Experience Cooperation Listed as Priority

On August 7, according to the press service of the Belarusian Ministry of Energy, following a meeting between Belarusian Energy Minister Denis Moroz and Uzbek Ambassador to Belarus Nouriddin Mamanov, the two sides agreed to draft a cooperation roadmap in the energy sector. The meeting focused on the prospects for Belarus-Uzbekistan energy cooperation and examined follow-up arrangements based on the consensus reached by the two countries' high-level officials during Uzbek President Shavkat Mirziyoyev's visit to Belarus in July. Among the proposed areas of cooperation, collaboration in the atomic energy sector was identified as a key component. According to the discussions, the Uzbekistan nuclear power plant project will draw on Belarusian experience...

2026-08-08

Russian nuclear power plants generate 129.6 billion kWh of electricity this year

Alexey Likhachev, CEO of Rosatom, recently stated that since the beginning of this year, Russian nuclear power plants have generated a cumulative total of 129.6 billion kWh of electricity, exceeding the target set by the Federal Antimonopoly Service of the Russian Federation by 7.8%. Likhachev noted that Russia is currently in its summer peak electricity consumption period, and nuclear power plants across the country are operating normally overall, with stable power generation and all safety requirements being met. He stated that hot weather does require operating entities to pay greater attention to cooling and heat reduction measures, but this is a seasonal factor that must be addressed in nuclear power plant operations. He pointed out that Russian nuclear power plants have fully considered different climatic conditions during their design and operation phases...

2026-08-08

China's First Homegrown Radiopharmaceutical Receives Dual FDA Breakthrough Therapy and Fast Track Designations

On August 6, Nuoyu Medical announced that the U.S. Food and Drug Administration (FDA) has officially granted Breakthrough Therapy Designation (BTD) and Fast Track Designation (FTD) to the company's independently developed 68Ga-NYM096. This marks the first product in China's original radiopharmaceutical field to receive FDA Breakthrough Therapy Designation, and the first to receive both FDA Breakthrough Therapy and Fast Track designations simultaneously, creating a milestone breakthrough in the radiopharmaceutical field. 68Ga-NYM096 is a small-molecule diagnostic radiopharmaceutical for renal cancer that specifically binds to CAIX, suitable for positron emission tomography (PET) imaging of suspected or confirmed metastatic clear cell renal cell carcinoma (c...

2026-08-08

StarRing Fusion Completes RMB 880 Million Series A++ Financing to Advance Fusion Device and Key Technology Engineering

StarRing Fusion recently announced the completion of a new Series A++ financing round, raising RMB 880 million. This round was jointly invested by Shenzhen Capital Group, Shendan Venture Capital, ABC Capital, BOCOM Investment, GGV Capital, Yongxin Ark, Keke Capital, Advantage Capital, and other institutions, with existing shareholder Shanghai Science and Technology Innovation Group's intellectual property fund and other institutions continuing to follow on. The company stated that the proceeds from this round, together with the previous Series A and A+ financing, will be used for the construction of the Shanghai Jiading experimental base, the construction and operation of the NTST negative-triangularity spherical tokamak, the design and construction of the CTRFR-1 "StarRing One," and the continued engineering advancement of key technologies including fusion-grade high-temperature superconducting magnets and AI-based plasma control...

2026-08-08

CNNC Fuzhi Officially Established, CNNC Isotope Holds 90% Stake to Integrate the Full Nuclear Medicine Industry Chain

On August 6, 2026, CNNC Fuzhi (Beijing) Technology Co., Ltd. (hereinafter referred to as "CNNC Fuzhi") was officially established. The company was jointly funded by CNNC Isotope Co., Ltd. (hereinafter referred to as "CNNC Isotope") and CNNC (Zhejiang) Innovation Co., Ltd. (hereinafter referred to as "CNNC Zhejiang Innovation"), with CNNC Isotope holding 90% of the shares and CNNC Zhejiang Innovation holding 10%. CNNC Fuzhi will take over the business of CNNC Isotope's Nuclear Medicine Development Center, focusing on deep cultivation in the smart nuclear medicine sector. With the smart nuclear medicine IoT system as its core carrier, the company aims to integrate the entire nuclear medicine industry chain, build a synergistic development model of "smart nuclear medicine system + nuclear drugs + equipment + services," and drive the business transition from single product supply to full value chain integration...

2026-08-08

CFHI and CGN Hold Exchange Meeting to Jointly Tackle HPR1000 2.0 Demonstration Project

On August 6, China First Heavy Industries (CFHI) and China General Nuclear Power Group (CGN) held an exchange meeting at CFHI's nuclear power and petrochemical equipment manufacturing base. Leaders from both sides, including Lu Zhiqiang, Secretary of the Party Committee and Chairman of CFHI, and Pang Songtao, Deputy Secretary of the Party Committee and General Manager of CGN, attended the meeting. The two sides reviewed and summarized two decades of cooperation achievements, jointly mapped out a blueprint for coordinated development across the entire industrial chain, and presented flags to the joint Party member task force for the HPR1000 2.0 demonstration project. Zhang Wenping, Member of the Standing Committee of the Party Committee and Chief Accountant of CFHI, presided over the meeting. As two central state-owned enterprises serving the national energy power strategy, the two sides have built a solid collaboration system in multiple fields since undertaking the first domestically produced Hongyanhe million-kilowatt-class reactor pressure vessel in 2006, including nuclear island main equipment, special forgings, nuclear three-waste treatment equipment, and complete wind turbines, jointly breaking the overseas monopoly on large nuclear power forgings, supporting the localization breakthrough and batch commissioning of the HPR1000, and jointly consolidating the foundation for the safe development of China's nuclear power industry.

2026-08-08

CNNC 24 Held a Meeting to Announce Leadership Team Adjustments

On August 7, CNNC 24 held a meeting to announce leadership team adjustments. Dai Xiongbiao, General Manager and Deputy Secretary of the Party Committee of China Nuclear Engineering Group (CNEC), attended the meeting and delivered a speech. Li Bing, Secretary of the Company's Party Committee and Chairman, presided over the meeting. Wang Linsen, General Manager of CNEC's Human Resources Department (Organization Department of the Party Committee), read out the appointment and removal decision: Wu Min was recommended as General Manager of CNNC 24 and appointed Deputy Secretary of the Party Committee of CNNC 24. Dai Xiongbiao emphasized that this adjustment is a major event in the leadership team building of CNNC 24, fully reflecting the care and support of the Group Company's Party Group for the Company's reform and development. It is necessary to deeply practice the requirements of "transforming concepts, strengthening capabilities, and improving quality and efficiency," make good use of the "Working Methods of the Party Committee," and continuously improve operational efficiency and management effectiveness...

2026-08-08

First Batch of Non-Safety-Class Main Instrumentation and Control Cabinets for Unit 1 of Xudabao Nuclear Power Plant Successfully Arrived

Recently, the non-safety-class main instrumentation and control (I&C) cabinets for Unit 1 of Xudabao Nuclear Power Plant arrived smoothly and were delivered to the plant site. The main I&C cabinets are core critical equipment for unit control and operation management at nuclear power plants, undertaking full-process functions such as data acquisition, logic calculation, process control, interlock protection, and operation monitoring. They can be regarded as the "central brain" ensuring the safe, controllable, and stable operation of nuclear power units. This equipment features high technical precision, strong integration, and stringent safety classification requirements, offering advantages such as high control accuracy, fast response speed, strong operational stability, and excellent fault tolerance, thereby ensuring safe, stable, and efficient unit operation. To ensure the equipment arrived on schedule, Liaoning Nuclear Power proactively took the lead, coordinated precisely, and efficiently linked the efforts of the general contractor, equipment manufacturer, and design institute, breaking through the collaborative chain across solution optimization, manufacturing, and factory acceptance testing, overcoming difficulties and advancing efficiently. By the end of July, all preparatory work was completed ahead of schedule, and the equipment arrived on time, laying a solid foundation for subsequent project milestones.

2026-08-08

Liu Mingsheng, Party Secretary and Chairman of SPIC, Conducts Research Visit to SPIC Laiyang

On August 6, Liu Mingsheng, Party Secretary and Chairman of State Power Investment Corporation (SPIC), conducted a research visit to SPIC Laiyang, where he conveyed and studied the spirit of the State Council Executive Meeting held on July 31, inspected the site of the Laiyang Nuclear Power Project, and chaired a research symposium. Liu Mingsheng affirmed the overall work approach of SPIC Laiyang. Liu Mingsheng pointed out that Laiyang Nuclear Power, as the first implementation project for the standardization and batch construction of "Guohe No.1", is of extremely significant importance to the Group's high-quality development of nuclear power. It is essential to conscientiously implement the spirit of the State Council Executive Meeting on July 31, construct and operate nuclear power units in accordance with the world's highest safety standards, always adhere to the principle of "safety first, quality first", prioritize nuclear safety at the highest level, and ensure absolute safety in nuclear operations. It is necessary to unify thinking, strengthen confidence, scientifically grasp opportunities and challenges, continuously enhance the maturity of the "Guohe No.1" reactor design, accelerate the improvement of its competitiveness, strengthen nuclear power construction management capabilities and talent team development, build the Laiyang Nuclear Power Project to high standards and high quality, polish the "Guohe No.1" brand, develop replicable and scalable management models and experience, and promote large-scale development.

2026-08-08

First Main Girder of Main Crane B Hoisted into Place in Conventional Island of Lufeng Nuclear Power Plant Unit 1

The first main girder of Main Crane B, the first main crane in the conventional island of Lufeng Nuclear Power Plant Unit 1, began lifting at 8:45 on August 7, 2026, and was positioned at 11:31. This marks the official commencement of main crane hoisting work in Conventional Island Unit 1; all hoisting work for Main Cranes A/B is expected to be completed by August 10. The main building of Conventional Island Unit 1 of Lufeng Nuclear Power Plant Unit 1 is equipped with two main cranes, designated Main Crane A and Main Crane B, arranged on the same level with a lifting capacity of 240t/40t each. These are critical lifting equipment for the nuclear power plant, primarily used during the construction phase for hoisting major conventional island equipment such as steam turbines, generators, condensers, moisture separator reheaters, and condensate pumps, as well as other installation work including piping and valves. During the operational phase of the nuclear power plant, they are used for maintenance of the turbine-generator unit and other in-plant items during overhaul periods.

2026-08-07

Professor Lin Guoxian from the BC Cancer Agency Delivers Academic Exchange at the Institute of Radiation Medicine, Chinese Academy of Medical Sciences

Lin Guoxian: Professor at the BC Cancer Agency, whose research focuses on the development of targeted radiopharmaceuticals for the diagnosis and treatment of various tumors. To date, he has led/participated in the publication of over 135 peer-reviewed journal articles, filed more than 30 patent applications related to radiopharmaceuticals, and completed the clinical translation of 7 self-developed radiopharmaceuticals for the diagnosis and treatment of multiple tumor types. During the seminar, Professor Lin Guoxian, based on his team's years of frontier exploration, systematically reviewed the research progress of nuclear drugs targeting PSMA for prostate cancer: first, the molecular design and clinical advantages of F-18 labeled PSMA-targeted PET imaging agents; second, the substantial improvement of tumor targeting of Lu-177 labeled therapeutic radiopharmaceuticals through rational optimization of molecular structures,...

2026-08-07